The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI–neuropathology diagnostic accuracy studyAndreas Charidimou, Steven M. Greenberg, M. Edip Gurol et al.|The Lancet Neurology|2022Cited by 651
Pharmacological targeting of the protein synthesis mTOR/4E‐BP1 pathway in cancer‐associated fibroblasts abrogates pancreatic tumour chemoresistanceCamille Duluc, Corinne Bousquet, Siham Moatassim-Billah et al.|EMBO Molecular Medicine|2015Cited by 196
Hypoxia Induces VEGF-C Expression in Metastatic Tumor Cells via a HIF-1α-Independent Translation-Mediated MechanismFlorent Morfoisse, Barbara Garmy‐Susini, Anna Kuchnio et al.|Cell Reports|2014Cited by 153
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drugJulie Guillermet‐Guibert, Corinne Bousquet, Lise Davenne et al.|Molecular Cancer Therapeutics|2009Cited by 139
Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16Mounira Chalabi‐Dchar, Corinne Bousquet, Stéphanie Cassant‐Sourdy et al.|Gastroenterology|2015Cited by 46